EP3287440A1 - Composé pyrrolidinoqie - Google Patents

Composé pyrrolidinoqie Download PDF

Info

Publication number
EP3287440A1
EP3287440A1 EP16783021.5A EP16783021A EP3287440A1 EP 3287440 A1 EP3287440 A1 EP 3287440A1 EP 16783021 A EP16783021 A EP 16783021A EP 3287440 A1 EP3287440 A1 EP 3287440A1
Authority
EP
European Patent Office
Prior art keywords
group
compound
formula
compound represented
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16783021.5A
Other languages
German (de)
English (en)
Other versions
EP3287440B1 (fr
EP3287440A4 (fr
Inventor
Tetsuya Ikemoto
Leopold Mpaka LUTETE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of EP3287440A1 publication Critical patent/EP3287440A1/fr
Publication of EP3287440A4 publication Critical patent/EP3287440A4/fr
Application granted granted Critical
Publication of EP3287440B1 publication Critical patent/EP3287440B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0271Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Definitions

  • the present invention relates to a pyrrolidine compound, a method for producing the pyrrolidine compound, and use of the pyrrolidine compound as a catalyst.
  • 3-Formyl-2-hydroxypropanoic acid compounds are useful as an active ingredient for medicines, agrochemicals and the like or as an intermediate in the production of medicines, agrochemicals and the like.
  • an optically active form of the compound is useful as an intermediate in the production of vitamins including pantothenic acid.
  • the present invention provides: a novel catalyst; a method for producing the catalyst; and a method for producing a 3-formyl-2-hydroxypropanoic acid compound using the catalyst.
  • the present invention provides:
  • the halogen atom refers to a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
  • the C 1 -C 8 perfluoroalkyl group represented by Rf refers to a group in which all of hydrogen atoms in a C 1 -C 8 alkyl group are substituted by fluorine atoms, and specific examples thereof include a trifluoromethyl group, a pentafluoroethyl group and a nonafluorobutyl group.
  • Rf is preferably a C 1 -C 4 perfluoroalkyl group, more preferably a trifluoromethyl group.
  • the C 1 -C 12 alkyl group represented by R refers to a linear or branched alkyl group having 1 to 12 carbon atoms, and specific examples thereof include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a neopentyl group, a 1-ethylpropyl group, a hexyl group, a 2,2-dimethylbutyl group, a heptyl group, an octyl group, a decyl group and a dodecyl group.
  • a C 1 -C 8 alkyl group is preferred, and a C 1 -C 4 alkyl group is particularly preferred.
  • the C 1 -C 12 alkoxy group represented by R refers to a linear or branched alkoxy group having 1 to 12 carbon atoms, and specific examples thereof include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, a tert-butoxy group, a neopentyloxy group, a hexyloxy group, an octyloxy group, a decyloxy group and a dodecyloxy group.
  • a C 1 -C 6 alkoxy group is preferred, and a C 1 -C 4 alkoxy group is particularly preferred.
  • a C 2 -C 7 alkoxycarbonyl group is preferred.
  • the C 1 -C 12 fluorinated alkyl group represented by R refers to a C 1 -C 12 alkyl group having a fluorine atom, and specific examples thereof include a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group, a 2,2-difluoroethyl group, a 3-fluoropropyl group, a 4-fluorobutyl group, an 8-fluorooctyl group and a 12-fluorododecyl group.
  • R is preferably a C 1 -C 12 alkyl group or a C 1 -C 12 fluorinated alkyl group, more preferably a C 1 -C 4 alkyl group or a C 1 -C 4 fluorinated alkyl group.
  • Particularly preferred specific examples of R include a methyl group, an ethyl group and a trifluoromethyl group.
  • m is preferably an integer of 0 to 2, more preferably 0.
  • Compound (1) has an asymmetric carbon atom, and therefore includes a compound represented by formula (1S) that is in an S steric configuration (hereinafter referred to as “compound (1S)”) and a compound represented by formula (1R) that is in an R steric configuration (hereinafter referred to as “compound (1R)").
  • Compound (1) can be used as a catalyst for the below-mentioned aldol reaction.
  • An optically active form of compound (1) can be used as an asymmetric catalyst.
  • compound (1) to be used in the asymmetric aldol reaction preferably has an enantiomeric excess of 90 ee% or more, more preferably 95 ee% or more.
  • Compound (1) can be synthesized by, for example, the following method. (wherein Rf, P G , R and m are as defined above.)
  • amino-group-protecting group examples include a C 1 -C 6 alkyl group (e.g., a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a neopentyl group, a 1-ethylpropyl group, a hexyl group, a 2,2-dimethylbutyl group, a 2-ethylbutyl group), a C 2 -C 6 alkenyl group (e.g., an ethenyl group, a 1-propenyl group, a 2-propenyl group, a 2-methyl-1-propenyl group, a 1-butenyl group, a 3-methyl-2-butenyl group, a 2-pen
  • amino-group-protecting group examples include an acetyl group, a trifluoroacetyl group, a pivaloyl group, a tert-butoxycarbonyl group, a 2,2,2-trichloroethoxycarbonyl group, a benzyl group, a benzyloxycarbonyl group, a 9-fluorenylmethyloxycarbonyl group, a benzhydryl group, a trityl group, a phthaloyl group, a p-toluenesulfonyl group and an o-nitrobenzenesulfonyl group.
  • the C 6 -C 10 aryl group refers to an aromatic monocyclic or polycyclic (condensed) hydrocarbon group having 6 to 10 carbon atoms, and specific examples thereof include a phenyl group, a 1-naphthyl group and a 2-naphthyl group.
  • the C 7 -C 14 aralkyl group refers to a group in which a C 6 -C 10 aryl group is bound to a C 1-4 alkyl group, and specific examples thereof include a benzyl group, a 1-phenylethyl group, a 2-phenylethyl group, a (naphthyl-1-yl)methyl group, a (naphthyl-2-yl)methyl group, a 1-(naphthyl-1-yl)ethyl group, a 1-(naphthyl-2-yl)ethyl group, a 2-(naphthyl-1-yl)ethyl group and a 2-(naphthyl-2-yl)ethyl group.
  • the tri-C 1 -C 6 alkylsilyl group refers to a silyl group having "three C 6 -C 6 alkyl groups", and specific examples thereof include a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group and a tert-butyldiethylsilyl group.
  • P G is preferably a C 7 -C 14 aralkyl group (preferably a benzyl group), a C 2 -C 7 alkoxycarbonyl group (preferably a tert-butoxycarbonyl group), a C 8 -C 15 aralkyloxycarbonyl group (preferably a benzyloxycarbonyl group) or a tri-C 1 -C 6 alkylsilyl group (preferably a trimethylsilyl group) in each of which a C 1 -C 6 alkyl group, a nitro group or a halogen atom may be bound on a benzene ring, and is particularly preferably a benzyl group.
  • Step 1 is a step of producing compound (3) from compound (2), and compound (3) can be produced by converting a hydroxyl group in compound (2) to a leaving group.
  • the leaving group include a halogen atom, a C 1 -C 6 alkanesulfonyloxy group (e.g., a methanesulfonyloxy group, an ethanesulfonyloxy group, a propanesulfonyloxy group), a C 1 -C 6 perfluoroalkanesulfonyloxy group (e.g., a trifluoromethanesulfonyloxy group, a pentafluoroethanesulfonyloxy group, a heptafluoropropanesulfonyloxy group), and a C 6 -C 10 arylsulfonyloxy group (e.g., a benzenesulfonyloxy group, a p-toluenesulfonyloxy group, a p-nitrobenzenesulfonyloxy group, an o-nitrobenzenesulfony
  • the leaving group is preferably a halogen atom, particularly preferably a chlorine atom.
  • the reaction for converting the hydroxyl group to the leaving group can be carried out by reacting a halogenating agent (e.g., thionyl chloride), a C 1 -C 6 alkanesulfonylating agent (e.g., methanesulfonyl chloride), a C 1 -C 6 perfluoroalkanesulfonylating agent (e.g., trifluoromethanesulfonyl chloride), a C 6 - 10 arylsulfonylating agent which may have a nitro group or the like (e.g., benzenesulfonyl chloride, p-toluenesulfonyl chloride, o-nitrobenzenesulfonyl chloride, p-nitrobenzenesulfonyl chloride) or the like with compound (2).
  • the amount of the reagent to be used is preferably 1 to 10 moles, more preferably 1 to 3
  • the reaction may be carried out in the presence of a base.
  • a base include: an inorganic base, such as sodium carbonate, potassium carbonate, cesium carbonate, sodium hydrogen carbonate and potassium hydrogen carbonate; and an organic base, such as pyridine, 2,6-lutidine, triethylamine, diisopropylethylamine, N-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene (DBN) and imidazole.
  • DBU 1,8-diazabicyclo[5.4.0]undec-7-ene
  • DBN 1,5-diazabicyclo[4.3.0]non-5-ene
  • the amount of the base to be used is preferably 10 moles or less, more preferably 1 to 5 moles, relative to 1 mole of compound (2), from the viewpoint of yield and economic performance.
  • the reaction is preferably carried out in a solvent.
  • the solvent include an aromatic hydrocarbon solvent (e.g., toluene, benzene, xylene); a halogenated hydrocarbon solvent (e.g., chloroform, dichloromethane, carbon tetrachloride); an ether solvent (e.g., diethyl ether, tetrahydrofuran (THF), 1,4-dioxane); an aprotic polar solvent (e.g., dimethylformamide (DMF), dimethylacetamide) ; and a solvent mixture of two or more of the above-mentioned solvents.
  • aromatic hydrocarbon solvent e.g., toluene, benzene, xylene
  • a halogenated hydrocarbon solvent e.g., chloroform, dichloromethane, carbon tetrachloride
  • an ether solvent e.g., diethyl ether, tetrahydro
  • a halogenated hydrocarbon solvent is preferred, and chloroform is particularly preferred, from the viewpoint of achieving good reactivity and good yield.
  • the amount of the solvent to be used is preferably 2 to 50 mL, more preferably 3 to 10 mL, relative to 1 g of compound (2).
  • reaction is carried out by a method in which a reagent such as a halogenating agent and a sulfonylating agent is added to a mixture of compound (2), the base and the solvent and then the resultant solution is mixed.
  • a reagent such as a halogenating agent and a sulfonylating agent is added to a mixture of compound (2), the base and the solvent and then the resultant solution is mixed.
  • the reaction temperature may vary depending on the types of compound (2), the reagent, the base and the solvent, and is preferably within the range from -20 to 80°C, more preferably from -10 to 50°C.
  • the reaction time may vary depending on the types of compound (2), the reagent, the base and the solvent and the reaction temperature, and is preferably 0.5 to 24 hours, more preferably 1 to 6 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (3) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (3) can be carried out by subjecting compound (3) to an extraction purification treatment, a distillation treatment, an adsorption treatment with activated carbon, silica, alumina or the like, or a chromatography treatment by silica gel column chromatography or the like.
  • Compound (3) may be subjected to the subsequent step in the form of the reaction mixture. Particularly from the viewpoint of yield and economic performance, it is preferred to use the reaction mixture containing compound (3), which is produced in step 1, without any modification in the subsequent step.
  • Step 2 is a step for producing compound (4) by the reaction of compound (3) with ammonia, and compound (4) can be produced by converting the leaving group in compound (3) to an amino group with ammonia.
  • Ammonia is generally used in the form of an aqueous solution or a solution in an alcohol (e.g., methanol, ethanol, isopropyl alcohol). Water or the alcohol may double as a solvent.
  • the amount of ammonia to be used is preferably 2 to 200 moles, more preferably 5 to 100 moles, relative to 1 mole of compound (3), from the viewpoint of yield and economic performance.
  • reaction is carried out by a method in which ammonia is added to the reaction mixture containing compound (3) and then the resultant solution is mixed.
  • the reaction temperature may vary depending on the types of compound (3) and the solvent, and is preferably within the range from 0 to 80°C, more preferably from 10 to 50°C.
  • the reaction time may vary depending on the types of compound (3) and the solvent and the reaction temperature, and is preferably 0.5 to 24 hours, more preferably 1 to 8 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (4) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (4) can be carried out by subjecting compound (4) to an extraction purification treatment, a distillation treatment, an adsorption treatment with activated carbon, silica, alumina or the like, or a chromatography treatment by silica gel column chromatography or the like.
  • Compound (4) may be subjected to the subsequent step in the form of the reaction mixture.
  • Step 3 is a step for producing compound (5) from compound (4), and compound (5) can be produced by reacting compound (4) with a C 1 -C 8 perfluoroalkanesulfonylating agent (e.g., a trifluoromethanesulfonylating agent).
  • a C 1 -C 8 perfluoroalkanesulfonylating agent e.g., a trifluoromethanesulfonylating agent.
  • C 1 -C 8 perfluoroalkanesulfonylating agent examples include trifluoromethanesulfonyl chloride, trifluoromethanesulfonic anhydride, pentafluoroethanesulfonyl chloride and nonafluorobutanesulfonyl chloride.
  • the amount of the C 1 -C 8 perfluoroalkanesulfonylating agent to be used is preferably 1 to 2 moles, more preferably 1.05 to 1.4 moles, relative to 1 mole of compound (4), from the viewpoint of yield and economic performance.
  • the reaction is generally carried out in the presence of a base.
  • a base include: an inorganic base, such as sodium carbonate, potassium carbonate, cesium carbonate, sodium hydrogen carbonate and potassium hydrogen carbonate; and an organic base, such as pyridine, 2,6-lutidine, triethylamine, diisopropylethylamine, N-methylmorpholine, DBU, DBN and imidazole, preferably triethylamine.
  • the amount of the base to be used is preferably 1 to 3 moles, more preferably 1.2 to 2 moles, relative to 1 mole of compound (4), from the viewpoint of yield and economic performance.
  • the reaction is generally carried out in a solvent.
  • the solvent include an aromatic hydrocarbon solvent (e.g., toluene, benzene, xylene); a halogenated hydrocarbon solvent (e.g., chloroform, dichloromethane, carbon tetrachloride) ; an ether solvent (e.g., diethyl ether, THF); an aprotic polar solvent (e.g., DMF, dimethylacetamide) ; and a solvent mixture of two or more of the above-mentioned solvents.
  • a halogenated hydrocarbon solvent is preferred, and chloroform is particularly preferred, from the viewpoint of achieving good reactivity and good yield.
  • the amount of the solvent to be used is preferably 3 to 50 mL, more preferably 5 to 25 mL, relative to 1 g of compound (4).
  • reaction is carried out by a method in which a trifluoromethanesulfonylating agent is added to a mixture of compound (4), the base and the solvent and then the resultant solution is mixed.
  • the reaction temperature may vary depending on the types of compound (4), the trifluoromethanesulfonylating agent, the base and the solvent, and is preferably within the range from -20 to 80°C, more preferably from -10 to 50°C.
  • the reaction time may vary depending on the types of compound (4), the trifluoromethanesulfonylating agent, the base and the solvent and the reaction temperature, and is preferably 1 to 24 hours, more preferably 3 to 12 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (5) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (5) can be carried out by subjecting compound (5) to an extraction-purification procedure, a distillation procedure, an adsorption procedure with activated carbon, silica, alumina or the like, or a chromatography procedure by silica gel column chromatography or the like.
  • Compound (5) may be subjected to the subsequent step in the form of the reaction mixture.
  • Step 4 is a step for producing compound (5) by the reaction of compound (3) with trifluoromethanesulfonamide or a salt thereof.
  • An example of the salt of trifluoromethanesulfonamide is a lithium salt.
  • Compound (3) may be used in the form of the reaction mixture produced in step 1. In this case, it is desirable to remove the remaining halogenating agent.
  • the amount of the trifluoromethanesulfonamide or a salt thereof to be used is preferably 0.8 to 3 moles, more preferably 1.1 to 2 moles, relative to 1 mole of compound (3), from the viewpoint of yield and economic performance.
  • the reaction is generally carried out in the presence of a base.
  • a base include: an inorganic base, such as sodium carbonate, potassium carbonate, cesium carbonate, sodium hydrogen carbonate and potassium hydrogen carbonate; and an organic base, such as pyridine, 2,6-lutidine, triethylamine, diisopropylethylamine, N-methylmorpholine, DBU, DBN and imidazole.
  • the amount of the base to be used is preferably 1 to 10 moles, more preferably 1.2 to 5 moles, relative to 1 mole of compound (3), from the viewpoint of yield and economic performance.
  • the reaction is preferably carried out in a solvent.
  • the solvent include an aromatic hydrocarbon solvent (e.g., toluene, benzene, xylene); a halogenated hydrocarbon solvent (e.g., chloroform, dichloromethane, carbon tetrachloride); an ether solvent (e.g., diethyl ether, tetrahydrofuran, 1,4-dioxane); an aprotic polar solvent (e.g., DMF, dimethylacetamide); and a solvent mixture of two or more of the above-mentioned solvents.
  • aromatic hydrocarbon solvent e.g., toluene, benzene, xylene
  • a halogenated hydrocarbon solvent e.g., chloroform, dichloromethane, carbon tetrachloride
  • an ether solvent e.g., diethyl ether, tetrahydrofuran, 1,4-diox
  • a halogenated hydrocarbon solvent is preferred, and chloroform is particularly preferred, from the viewpoint of achieving good reactivity and good yield.
  • the amount of the solvent to be used is preferably 2 to 100 mL, more preferably 2.5 to 10 mL, relative to 1 g of compound (3).
  • reaction is carried out by a method in which trifluoromethanesulfonamide or a salt thereof and the base are added to a mixture of compound (3) and the solvent and then the resultant solution is mixed.
  • the reaction temperature may vary depending on the types of compound (3), the base and the solvent, and is preferably within the range from 0 to 120°C, more preferably from 20 to 80°C.
  • the reaction time may vary depending on the types of compound (3), the base and the solvent and the reaction temperature, and is preferably 0.5 to 24 hours, more preferably 1 to 8 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (5) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (5) can be carried out by subjecting compound (5) to an extraction-purification procedure, a distillation procedure, an adsorption procedure with activated carbon, silica, alumina or the like, or a chromatography procedure by silica gel column chromatography or the like.
  • Compound (5) may be subjected to the subsequent step in the form of the reaction mixture.
  • Step 5 is a step for producing compound (1) by deprotecting compound (5).
  • the deprotection can be carried out by, for example, a known method disclosed in " Protective Groups in Organic Synthesis", attributed to T. W. Greene and P. G. M. Wuts (published by Wiley-Interscience, fourth edition, 2006 ).
  • the deprotection can be carried out by reacting compound (5) in the presence of a catalyst and a hydrogen source.
  • the catalyst include palladium-carbon, palladium black, palladium chloride, palladium hydroxide, rhodium-carbon, platinum oxide, platinum black, platinum-palladium, raney nickel and raney cobalt.
  • the amount of the catalyst to be used is preferably 0.001 to 0.5 g, more preferably 0.05 to 0.15 g, relative to 1 g of compound (5), from the viewpoint of yield and economic performance.
  • the hydrogen source include a hydrogen gas, ammonium formate and cyclohexadiene.
  • the amount of the hydrogen source to be used is preferably 1 to 5 moles, more preferably 1 to 3 moles, relative to 1 mole of compound (5).
  • the hydrogen gas is generally used under a pressure of 0.1 to 1.0 Mpa, due to the limitation with respect to experimental facilities.
  • the reaction is carried out in a solvent.
  • the solvent include an aromatic hydrocarbon solvent (e.g., toluene, benzene, xylene); an aliphatic hydrocarbon solvent (e.g., hexane, heptane, cyclohexane); an alcohol solvent (e.g., methanol, ethanol); an ether solvent (e.g., diethyl ether, THF); an ester solvent (e.g., ethyl acetate, isopropyl acetate) ; water; or a mixture of two or more of these solvents.
  • an alcohol solvent is preferred, and methanol is particularly preferred, from the viewpoint of achieving good reactivity and good yield.
  • the reaction is carried out by a method in which the compound (5), the catalyst and the solvent are mixed together, then the hydrogen source is added to the resultant mixture and then the resultant solution is mixed, or the like.
  • the reaction temperature may vary depending on the types of compound (5), the catalyst, the hydrogen source and the solvent, and is preferably within the range from 0 to 60°C, more preferably from 10 to 50°C.
  • the reaction time may vary depending on the types of compound (5), the catalyst, the hydrogen source and the solvent and the reaction temperature, and is preferably 1 to 20 hours, more preferably 1 to 10 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (1) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (1) can be carried out by subjecting compound (1) to an extraction-purification procedure, a distillation procedure, an adsorption procedure with activated carbon, silica, alumina or the like, or a chromatography procedure by silica gel column chromatography or the like.
  • Compound (2) to be used in the production of compound (1) can be produced through, for example, the following route.
  • an optically active form of compound (2) can be produced.
  • Compound (1) can be used in an aldol reaction as shown below. Particularly, an optically active form of compound (1) can be used in an asymmetric aldol reaction to produce an optically active form of compound (III).
  • Examples of the protecting group for a carboxyl group (hereinafter referred to as "carboxyl-group-protecting group”) represented by R 1 include a C 1 -C 6 alkyl group, a C 7 -C 14 aralkyl group, a phenyl group, a trityl group and a tri-C 1 -C 6 alkylsilyl group, and specific example thereof include a methyl group, an ethyl group, a tert-butyl group, a benzyl group, a trityl group, a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group and a tert-butyldiethylsilyl group.
  • R 1 is preferably a C 1 -C 6 alkyl group, more preferably a C 1 -C 4 alkyl group, particularly preferably an ethyl group.
  • hydroxyl-group-protecting group represented by R 2
  • R 2 Specific examples of the protecting group for a hydroxyl group (hereinafter referred to as "hydroxyl-group-protecting group") represented by R 2 include a C 1 -C 6 alkyl group, a phenyl group, a trityl group, a C 7 -C 14 aralkyl group, a formyl group, a C 2 -C 7 alkylcarbonyl group, a benzoyl group, a C 8 -C 15 aralkylcarbonyl group, a 2-tetrahydropyranyl group, a 2-tetrahydrofuranyl group, a tri-C 1 -C 6 alkylsilyl group, a succinimidoxycarbonyl group, a C 7 -C 11 arylcarbonyl group, a C 7 -C 11 aryloxycarbonyl group and a C 8 -C 15 aralkyloxycarbonyl group.
  • hydroxyl-group-protecting group examples include a benzyl group, an acetyl group, a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group, a tert-butyldiethylsilyl group, a succinimidoxycarbonyl group, a phenoxycarbonyl group and a benzyloxycarbonyl group.
  • R 2 is preferably a C 7 -C 14 aralkyl group, particularly preferably a benzyl group.
  • the above-mentioned aldol reaction is a reaction in which compound (I), which is a glyoxylic acid derivative, or a polymer thereof with compound (II) in the presence of compound (1) to produce compound (III).
  • the polymer of compound (I) is a compound represented by formula (I-1): (wherein n1 represents an integer of 2 or more; and R 1 is as defined above) or a cyclic polymer compound, and a typical example of the cyclic polymer compound is a trimer represented by the following formula: (wherein R 1 is as defined above).
  • Compound (I) is commercially available, and a commercially available product can be used without any modification.
  • Each of compound (I) and a polymer thereof is also commercially available in the form of a solution (e.g., a solution in toluene (also referred to as a "toluene solution”, hereinafter)), and the commercially available toluene solution can be used without any modification.
  • a solution in toluene also referred to as a "toluene solution”, hereinafter
  • the aldol reaction is preferably carried out in a solvent.
  • the solvent include: an aromatic hydrocarbon solvent (e.g., toluene, benzene, xylene); an aliphatic hydrocarbon solvent (e.g., hexane, heptane, cyclohexane); an alcohol solvent (e.g., methanol, ethanol, 2-propanol, 2-methyl-2-propanol); a halogenated hydrocarbon solvent (e.g., chloroform, dichloromethane, carbon tetrachloride, 1-chlorobutane); an ether solvent (e.g., diethyl ether, THF, 2-methyltetrahydrofuran, 1,2-dimethoxyethane (ethylene glycol dimethyl ether (EGDE)), methyl tert-butyl ether, ethyl tert-butyl ether, diisopropyl ether, dibutyl ether, cyclopen
  • an aromatic hydrocarbon solvent an alcohol solvent; a halogenated hydrocarbon solvent; an ether solvent; a nitrile solvent; water; a solvent mixture of the aforementioned solvents, and the like are preferred.
  • At least one solvent selected from the group consisting of NMP, DMI, DMF, acetonitrile, THF, EGDE, toluene, chloroform, methanol and water it is more preferred to use a mixture of two solvents selected from the aforementioned solvents, and it is particularly preferred to use a solvent mixture of water and NMP or water and DMI.
  • the amount of compound (I) to be used is preferably 0.5 to 10 moles, more preferably 0.8 to 2 moles, relative to 1 mole of compound (II), from the viewpoint of economic performance.
  • the aldol reaction can be carried out by: a method in which compound (II), compound (1) and the solvent are added to a polymer of compound (I) and the resultant solution is mixed; a method in which a polymer of compound (I), compound (1) and the solvent are mixed together, then compound (II) is added to the solution, and the resultant solution is mixed; a method in which compound (II), compound (1) and the solvent are mixed together, then a polymer of compound (I) is added to the solution, and the resultant solution is mixed; and the like.
  • the aldol reaction by: a method in which compound (II), compound (1) and the solvent are mixed together, then a polymer of compound (I) is added to the solution and then the resultant solution was mixed; or a method in which a polymer of compound (I), compound (1) and the solvent are mixed together, then the compound (II) is added to the solution and then the resultant solution is mixed.
  • the amount of compound (1) to be used is preferably 0.1 to 30 mol%, more preferably 0.5 to 15 mol%, relative to the amount of compound (II), from the viewpoint of yield and economic performance.
  • the reaction temperature may vary depending on the types of compound (II), and is preferably within the range from -20 to 100°C, more preferably from -10 to 40°C.
  • the reaction time may vary depending on the types of compound (II) and the reaction temperature, and is preferably 1 to 100 hours, more preferably 3 to 50 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of compound (III) contained in a reaction mixture thus produced can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of compound (III) can be carried out by subjecting compound (III) to an extraction-purification procedure, a distillation procedure, an adsorption procedure with activated carbon, silica, alumina or the like, or a chromatography procedure by silica gel column chromatography or the like.
  • an optically active form of compound (1) in which m is 0 or an optically active form of compound (1) in which R is a methyl group, an ethyl group or a trifluoromethyl group depending on the types of compound (II), and it is particularly preferred to use an optically active form of compound (1) in which m is 0.
  • an optically active form of the anti-form compound (III), i.e., a compound represented by formula (IIIR) (hereinafter referred to as “compound (IIIR) ”) or a compound represented by formula (IIIS) (hereinafter referred to as “compound (IIIS)”): can be produced preferentially.
  • Compound (IIIR) is produced preferentially in the case where an S-form of compound (1) is used as a catalyst
  • compound (IIIS) is produced preferentially in the case where an R-form of compound (1) is used as a catalyst, wherein the diastereomer ratio (i.e., a syn/anti ratio) can become 50/50 or more. It becomes possible to achieve such selectivity that the diastereomer ratio (syn/anti ratio) is 20/80 or more, more preferably 10/90 or more.
  • the enantiomeric excess can become 50 ee% or more. It becomes possible to achieve such selectivity that the enantiomeric excess is 80 ee% or more, more preferably 90 ee% or more.
  • an optically active form of compound (III) to an optically active form of a corresponding acetal compound, i.e., a compound represented by formula (IV): (wherein R 1 and R 2 are as defined above; and R 3 represents a C 1 -C 12 alkyl group, a C 2 -C 12 alkenyl group, a C 2 -C 12 alkynyl group or a C 7 -C 14 aralkyl group) (hereinafter referred to as "compound (IV)").
  • R 3 is preferably a C 1 -C 12 alkyl group, more preferably a C 1 -C 8 alkyl group, still more preferably a C 1 -C 4 alkyl group, still more preferably a C 1 -C 3 alkyl group, particularly preferably a methyl group.
  • An optically active form of compound (IV) can be produced by reacting a reaction mixture (which contains an optically active form of compound (III) and is obtained after the completion of the asymmetric aldol reaction) or an optically active form of compound (III) (which is isolated but is not purified yet) with an alcohol compound represented by the following formula: R 3 OH (wherein R 3 is as defined above) or an orthoformate compound represented by the following formula: HC(OR 3 ) 3 (wherein R 3 is as defined above) in the presence of an acid catalyst.
  • the amount of the alcohol compound to be used is preferably 2 to 200 moles, more preferably 10 to 100 moles, relative to 1 mole of the optically active form of compound (III), from the viewpoint of yield and economic performance.
  • the alcohol compound is generally used as a reaction solvent.
  • the acid catalyst examples include pyridinium p-toluenesulfonate, and p-toluenesulfonic acid or a monohydrate thereof. From the viewpoint of reaction selectivity, pyridinium p-toluenesulfonate is preferred.
  • the amount of the acid catalyst to be used is preferably 0.01 to 1 moles, more preferably 0.01 to 0.1 moles, relative to 1 mole of the optically active form of compound (III), from the viewpoint of reactivity and economic performance.
  • the reaction can be carried out by: a method in which an alcohol compound and an acid catalyst are added to an optically active form of compound (III), which is isolated but is not purified yet, and then the resultant solution is mixed; a method in which an acid catalyst is added to an optically active form of compound (III), which is isolated but is not purified yet, then an alcohol compound is added to the solution, and the resultant solution is mixed; or the like. From the viewpoint of simplifying the operations, it is preferred to carry out the reaction by a method in which an alcohol compound and an acid catalyst are added to an optically active form of compound (III), which is isolated but is not purified yet, and then the resultant solution is mixed.
  • the reaction temperature may vary depending on the types of the alcohol compound and the acid catalyst, and is preferably within the range from 0 to 100°C, more preferably from 20 to 80°C, particularly preferably from 40 to 60°C.
  • the reaction time may vary depending on the types of the alcohol compound and the acid catalyst and the reaction temperature, and is preferably 10 minutes to 50 hours, more preferably 30 minutes to 20 hours, particularly preferably 1 to 10 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the amount of the orthoformate compound to be used is preferably 1 to 50 moles, more preferably 3 to 30 moles, relative to 1 mole of the optically active form of compound (III), from the viewpoint of yield and economic performance.
  • the acid catalyst examples include p-toluenesulfonic acid or a monohydrate thereof and pyridinium p-toluenesulfonate. From the viewpoint of yield and economic performance, p-toluenesulfonic acid or a monohydrate thereof is preferred.
  • the amount of the acid catalyst to be used is preferably 0.01 to 1 mole, more preferably 0.01 to 0.2 mole, relative to 1 mole of the optically active form of compound (III), from the viewpoint of the reaction rate.
  • the reaction can be carried out by: a method in which an orthoformate compound and an acid catalyst are added to a reaction mixture containing an optically active form of compound (III), which is obtained after the completion of the asymmetric aldol reaction, and then the resultant solution is mixed; a method in which an acid catalyst is added to a reaction mixture containing an optically active form of compound (III), which is obtained after the completion of the aldol reaction, then an orthoformate compound is added to the solution, and the resultant solution is mixed; or the like.
  • the reaction temperature may vary depending on the types of the orthoformate compound and the acid catalyst, and is preferably within the range from 0 to 100°C, more preferably from 10 to 40°C, particularly preferably from 20 to 30°C.
  • the reaction time may vary depending on the types of the orthoformate compound and the acid catalyst and the reaction temperature, and is preferably 10 minutes to 50 hours, more preferably 30 minutes to 20 hours, particularly preferably 1 to 10 hours.
  • the degree of progression of the reaction can be confirmed by an analysis means such as thin-layer chromatography, gas chromatography and high-performance liquid chromatography.
  • the isolation of the optically active form of compound (IV), which is contained in a mixture produced by the reaction with the alcohol compound or the orthoformate compound, can be carried out by subjecting the reaction mixture to a work-up procedure (e.g., neutralization, extraction, washing with water, distillation, crystallization).
  • the purification of the optically active form of compound (IV) can be carried out by subjecting the optically active form of compound (IV) to a recrystallization procedure, an extraction-purification procedure, a distillation procedure, an adsorption procedure with activated carbon, silica, alumina or the like, or a chromatography procedure by silica gel column chromatography or the like.
  • the optically active form of compound (IV) thus produced is measured with respect to the diastereomer ratio (syn/anti ratio) and enantiomeric excess thereof.
  • the measured diastereomer ratio (syn/anti ratio) and enantiomeric excess correspond to those of the optically active form of the compound (III) .
  • Ethyl glyoxylate was used in the form of a 50.8% toluene solution of a polymer purchased from JIAXING JLIGHT. All of liquid aldehydes and solvents other than ethyl glyoxylate were distilled before use.
  • FT-IR spectra were measured with JASCO FT/IR-410 spectrometer.
  • HPLC analysis was carried out using CHIRALCEL OB-H (0.46 cm ⁇ 25 cm), CHIRALPAK IA (0.46 cm ⁇ 25 cm) and CHIRALPAK IB (0.46 cm ⁇ 25 cm) while monitoring the UV detection with HITACHI Elite LaChrom Series HPLC.
  • the diastereomer ratio was measured by HPLC using reverse-phase column column pack C 18 MGIII (150 ⁇ 4.6 mm, 5 ⁇ m) under the following conditions.
  • the enantiomeric excess was measured by HPLC with arranging reverse-phase column CHIRALPAK AS-RH (4.6 mm ⁇ 150 mm, 5 ⁇ m) and L-column ODS (4.6 mm ⁇ 15 mm, 5 ⁇ m) tandemly under the following conditions.
  • a compound II (1258.7 mg, a 70% toluene solution, 5.0 mmol) was added to a mixture of a solution of a polymer of compound (I) (1225.1 mg, a 50.8% toluene solution, 6.0 mmol), a catalyst a (78.5 mg, 0.15 mmol), water (270 ⁇ L) and a solvent shown in Table 2 (1.3 mL).
  • the resultant mixture was stirred at room temperature (25-35°C). After 20 hours, trimethyl orthoformate (10.6 g, 100 mmol) and p-toluenesulfonic acid monohydrate (47.6 mg, 0.25 mmol) were added sequentially to the mixture, and the resultant mixture was stirred at room temperature for 3 hours.
  • each of the yields of Examples 4-1 and 4-4 was a yield of the isolated compound IV, and the yield of each of other Examples was determined by adding biphenyl (154.2 mg, 1.0 mmol) as an internal reference to the reaction mixture and was measured by HPLC. The diastereomer ratio and the enantiomeric excess were determined in the same manner as in Example 2.
  • p-Fluorophenyl magnesium bromide 140 ml, 140 mmol was added dropwise to a solution of N-benzylproline methyl ester (11 g, 50 mmol) in THF (150 ml), which was cooled to 0°C, and the resultant mixture was refluxed for three hours after the completion of the dropwise addition.
  • the mixture was cooled to room temperature, then an aqueous ammonium chloride solution (75 ml) was added to the mixture, and then 1 N hydrochloric acid (75 ml) was further added to the mixture.
  • the pH value of the mixture was adjusted to about 7.5 with a 2 N aqueous sodium hydroxide solution, and the mixture was extracted with ethyl acetate (3 ⁇ 150 mL). An organic layer was washed with brine (2 ⁇ 150 mL), the washed solution was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. A slurry prepared by adding ethyl acetate (10 mL) and heptane (200 mL) to the residue was refluxed for 1 hour.
  • the resultant solution was air-cooled to produce a solid material, and the solid material was filtrated, was then washed with ethyl acetate/heptane (1/20, 150 mL) and then dried to produce a desired material as a yellow solid material (14.5 g, 75%).
  • the present invention provides compound (1) which can be used as a catalyst.
  • compound (1) which can be used as a catalyst.
  • an aldol reaction is carried out in the presence of compound (1), a 3-formyl-2-hydroxypropanoic acid compound can be produced.
  • an optically active form of compound (1) is used, an optically active form of a 3-formyl-2-hydroxypropanoic acid compound can be produced with good selectivity.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
EP16783021.5A 2015-04-21 2016-04-08 Compose pyrrolidinique Active EP3287440B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015086929 2015-04-21
PCT/JP2016/061479 WO2016171000A1 (fr) 2015-04-21 2016-04-08 Composé pyrrolidinoqie

Publications (3)

Publication Number Publication Date
EP3287440A1 true EP3287440A1 (fr) 2018-02-28
EP3287440A4 EP3287440A4 (fr) 2018-09-12
EP3287440B1 EP3287440B1 (fr) 2019-03-27

Family

ID=57143982

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16783021.5A Active EP3287440B1 (fr) 2015-04-21 2016-04-08 Compose pyrrolidinique

Country Status (5)

Country Link
US (1) US10040760B2 (fr)
EP (1) EP3287440B1 (fr)
JP (1) JP6680296B2 (fr)
CN (1) CN107531624B (fr)
WO (1) WO2016171000A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5559608B2 (ja) * 2010-06-01 2014-07-23 住友化学株式会社 光学活性な3−置換−3−ホルミル−2−ヒドロキシプロパン酸化合物の製造方法
ES2657227T3 (es) 2012-08-09 2018-03-02 Sumitomo Chemical Company, Limited Método para producir un derivado de hexahidrofurofuranol

Also Published As

Publication number Publication date
CN107531624B (zh) 2020-10-02
EP3287440B1 (fr) 2019-03-27
JP6680296B2 (ja) 2020-04-15
CN107531624A (zh) 2018-01-02
JPWO2016171000A1 (ja) 2018-02-15
US10040760B2 (en) 2018-08-07
US20180127364A1 (en) 2018-05-10
WO2016171000A1 (fr) 2016-10-27
EP3287440A4 (fr) 2018-09-12

Similar Documents

Publication Publication Date Title
EP2958883B1 (fr) Compositions de cyclohexénone et leur procédé de préparation
US20210139462A1 (en) Process for the preparation of a sulfonamide structured kinase inhibitor
KR101653025B1 (ko) 2-아미노-4-트리플루오로메틸피리딘류의 제조 방법
EP2958893B1 (fr) Synthèse asymétrique d'un pyrrolidine-2-carboxamide substitué
KR20080023730A (ko) 신규한 피로카테킨 유도체
EP3287440B1 (fr) Compose pyrrolidinique
US7705161B2 (en) Process for producing nitrogenous 5-membered cyclic compound
KR101379383B1 (ko) 고순도 ⒮―메토프롤롤의 제조방법
KR101871567B1 (ko) 베타-아미노-다이싸이오에스터 화합물의 제조방법 및 이에 의해 제조된 베타-아미노-다이싸이오에스터 화합물
KR101525493B1 (ko) 고순도 탐술로신 또는 이의 염 제조방법
CA2724450A1 (fr) Procede de production d'un derive d'aminoalcool optiquement actif
CN110894186B (zh) 匹莫范色林及其中间体的制备方法
JP2012240959A (ja) 光学活性β−アミノチオールまたは光学活性β−アミノスルホン酸誘導体の合成法
US20040077098A1 (en) Optical resolver and method of optically resolving alcohol with the same
RU2795581C2 (ru) Синтез замещенных конденсированных с гетероциклом гаммакарболинов
JP5695434B2 (ja) 光学活性含フッ素2,3−ジヒドロピリドン誘導体及びその製造方法。
KR101973751B1 (ko) 테트라하이드로퀴놀린 유도체의 제조방법
JP4568002B2 (ja) 光学活性な2−フルオロ−1,3−ジオール誘導体およびその製造方法
KR20160008873A (ko) 신규의 베타-술핀아미노 말로네이트 유도체 및 이의 제조방법, 그리고 이를 이용한 시타글립틴의 제조방법
JP4374088B2 (ja) 新規な4,4−ジフルオロベンゾアゼピンケタール誘導体、およびそれを経由する4,4−ジフルオロベンゾアゼピン−5−オン誘導体の製造方法
US20100174073A1 (en) Process for the preparation of alfuzosin and salts thereof
WO2013168780A1 (fr) Procédé de production d'un ester d'acide 2-vinylcyclopropane-1,1- dicarboxylique optiquement actif
KR20050062944A (ko) 디이소프로필((1-((2-아미노-6-클로로-9h-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
CN110003022A (zh) 一种达泊西汀中间体的合成方法及其中间体
WO2017098975A1 (fr) Procédé de production d'un composé biphényle

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180810

RIC1 Information provided on ipc code assigned before grant

Ipc: C07B 61/00 20060101ALI20180806BHEP

Ipc: C07D 207/08 20060101ALI20180806BHEP

Ipc: C07D 207/09 20060101AFI20180806BHEP

Ipc: C07C 67/343 20060101ALI20180806BHEP

Ipc: C07C 69/716 20060101ALI20180806BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20181109

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1112894

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190415

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016011667

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190627

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20190327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190627

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190628

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1112894

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190727

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190727

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190408

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016011667

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190430

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190430

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

26N No opposition filed

Effective date: 20200103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20160408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230516

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230321

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240320

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240320

Year of fee payment: 9